Pony Biomedical Technology (Shanghai) Co., Ltd (hereinafter referred to as Pony Medicine) now has two major business base in both Beijing and Shanghai equipped with over 40000 ㎡ laboratory. We are a comprehensive technical service platform integrating drug design, drug synthesis, synthesis process development, drug activity screening, preparation research, pharmacodynamic evaluation, pharmacokinetic evaluation, toxicological evaluation and new drug registration. And we’ve been qualified with CMA, CNAS, GMP and GLP, as well as widely recognized by national drug ministries and commissions at home and overseas. Nowadays, the core R&D personnel of the laboratory are all overseas doctors with many years’ research and development experience in large international pharmaceutical enterprises and CROs, and senior professionals in the domestic drugs, who are engaged in and have accumulated rich R&D and industrialization experience in multi-chiral-center drug synthesis, multi-step drug synthesis, slow and controlled release preparation technology, liposome technology, nano preparation technology, low limit substance detection, unknown substance detection, pharmacodynamics & pharmacokinetics, preclinical toxicological safety evaluation, etc. The research fields involve drugs on tumor, cardiovascular, cerebrovascular, hypertension, infection, digestive system, mental and nervous system, etc.